Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction
Circulation · 11.04.2023 · 147 (15) · 1147-1161
DOI: 10.1161/circulationaha.122.061846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 11.04.2023. Verfasst von Virginia S Hahn und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology (V.S.H., S.M., N.K., E.J.Y., D.A.K., K.S.), Johns Hopkins University School of Medicine, Baltimore, MD. Hauptthemen laut MEDLINE: Heart Failure, Diabetes Mellitus. Die Arbeit wurde bisher 302-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
The human heart primarily metabolizes fatty acids, and this decreases as alternative fuel use rises in heart failure with reduced ejection fraction (HFrEF). Patients with severe obesity and diabetes are thought to have increased myocardial fatty acid metabolism, but whether this is found in those who also have heart failure with preserved ejection fraction (HFpEF) is unknown.
Methods
Plasma and endomyocardial biopsies were obtained from HFpEF (n=38), HFrEF (n=30), and nonfailing donor controls (n=20). Quantitative targeted metabolomics measured organic acids, amino acids, and acylcarnitines in myocardium (72 metabolites) and plasma (69 metabolites). The results were integrated with reported RNA sequencing data. Metabolomics were analyzed using agnostic clustering tools, Kruskal-Wallis test with Dunn test, and machine learning.
Results
Agnostic clustering of myocardial but not plasma metabolites separated disease groups. Despite more obesity and diabetes in HFpEF versus HFrEF (body mass index, 39.8 kg/m 2 versus 26.1 kg/m 2 ; diabetes, 70% versus 30%; both P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology (V.S.H., S.M., N.K., E.J.Y., D.A.K., K.S.), Johns Hopkins University School of Medicine, Baltimore, MD.
- Cardiovascular Institute, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (C.P., M.-S.K., K.C.B., K.B.M., Z.A., D.P.K.).
- Department of Cardiac Surgery (H.W.), Johns Hopkins University School of Medicine, Baltimore, MD.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
Zitieren
APA
Hahn, V. S., Petucci, C., Kim, M. S., Bedi, K. C., Wang, H., Mishra, S., Koleini, N., Yoo, E. J., Margulies, K. B., Arany, Z., Kelly, D. P., Kass, D. A., & Sharma, K. (2023). Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction. Circulation, 147(15), 1147-1161. https://doi.org/10.1161/circulationaha.122.061846
Vancouver
Hahn VS, Petucci C, Kim MS, Bedi KC, Wang H, Mishra S, et al. Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction. Circulation. 2023;147(15):1147-1161. doi:10.1161/circulationaha.122.061846
BibTeX
@article{Hahn2023,
author = {Hahn, Virginia S and Petucci, Christopher and Kim, Min-Soo and Bedi, Kenneth C and Wang, Hanghang and Mishra, Sumita and Koleini, Navid and Yoo, Edwin J and Margulies, Kenneth B and Arany, Zoltan and Kelly, Daniel P and Kass, David A and Sharma, Kavita},
title = {Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction},
journal = {Circulation},
year = {2023},
volume = {147},
number = {15},
pages = {1147--1161},
doi = {10.1161/circulationaha.122.061846}
}
EUVIMED